The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
beta-thioguanine deoxyriboside
A thiopurine nucleoside derivative with antineoplastic activity. After conversion to the triphosphate, beta-thioguanine deoxyriboside is incorporated into DNA, resulting in inhibition of DNA replication. This agent is cytotoxic against leukemia cell lines and has demonstrated some activity against leukemia cells in vivo. Beta-thioguanine deoxyriboside demonstrates antineoplastic activity against 6-thioguanine-resistant tumor cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Abbreviations: | | BTG B-TGDR | |
| |||
| Chemical structures: | | 1,9-dihydro-6H-purine-6-thione, 2-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl) 2'-deoxythioguanosine 2'-desoxy-6-thioguanosine 6-mercaptoguaninedeoxyriboside 9H-purine-6-thiol, 2-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl) monohydrate beta-2'-deoxy-6-thioguanosine beta-2'-deoxythioguanosine beta-2'-deoxythiol guanosine thioguanine 9-.beta-D-2'-deoxyriboside | |
| |||
